BioSpace News Archive

Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, today announced that the U.S. Food and Drug Administration (FDA) cleared the company to initiate its Phase 1 clinical trial of PIPE-791 in healthy volunteers.

Techdow USA Announces Launch of its Generic Lovenox ® , (Enoxaparin Sodium – Preservative Free) in Prefilled Syringes.

Vera Therapeutics, Inc. today announced that the Company’s management team will participate in the 44th Annual Goldman Sachs Global Healthcare Conference, which is taking place in Dana Point, CA from June 12 – 15, 2023.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic conferences, including the European Hematology Association (EHA) 2023 Congress, the European Human Genetics (ESHG) 2023 Conference and the European Association for Cancer Research (EACR) 2023 Congress.

Candel Therapeutics, Inc. today announced the appointment of Nicoletta Loggia, PhD, RPh, to the Company’s Board of Directors (Board) effective June 7, 2023.

Precipio, Inc. today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000 shares of the Company’s common stock and pre-funded warrants to purchase 319,445 shares of the Company’s common stock.

DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on June 23rd from 2:30 PM until approximately 5:00 PM PST (5:30 PM – 8:00 PM EST).

Medical Technology Associates is pleased to announce the acquisition of Premier Medical, Inc. (“Premier”).

andros today announced that Jeff Fritz , formerly the CEO of Revel Health (Now Icario), Lighthouse1 (Now Wex Health), and Storyworks OnDemand (Now Episerver), will succeed andros Founder Mike Simmons as CEO of andros.